Polycystic Ovary Syndrome (PCOS) Clinical Trial
Official title:
Department of Traditional Chinese Medicine (TCM), Center for Reproductive Medicine, Department of Obstetrics and Gynaecology, Peking University Third Hospital, Beijing 100191, China.
To determine the efficacy and safety of 2 different treatment modalities: 1) acupuncture plus lifestyle management (treatment group), 2) placebo plus lifestyle management (control group) in the treatment of insulin resistance in PCOS patients.
A prospective, randomized controlled trial design was used to select women with polycystic ovary syndrome as the research subjects. 144 subjects who met the inclusion and exclusion criteria were randomly divided into an acupuncture plus lifestyle intervention group (treatment group) and a placebo plus lifestyle intervention group (control group). The differences in glucose metabolism and reproductive endocrinology were compared between the two groups. 1. To verify the efficacy and safety of acupuncture intervention on insulin resistance in PCOS; 2. To explore the effects of acupuncture on androgen and lipid levels, ovarian function, reproductive dysfunction, mood and quality of life in women with PCOS. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01927471 -
Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
|
||
Completed |
NCT01927432 -
Ultrasound Characterization of Ovarian Follicle Dynamics in Women With Amenorrhea
|
||
Completed |
NCT00805207 -
Sex Steroids, Sleep, and Metabolic Dysfunction in Women
|
N/A | |
Completed |
NCT01999686 -
PCOS Treatment Using DLBS3233, Metformin, and Combination of Both
|
Phase 3 | |
Completed |
NCT03414957 -
Malay Women With PCOS and Their Association With Metabolic Syndrome
|
||
Recruiting |
NCT06143527 -
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS
|
Phase 1 | |
Recruiting |
NCT05394142 -
A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
|
Phase 2 | |
Completed |
NCT01233206 -
Metformin in High Responder Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF Cycles
|
Phase 4 | |
Not yet recruiting |
NCT05272657 -
Low-Carb Versus Mediterranean Diet in PCOS
|
N/A | |
Completed |
NCT01733459 -
Efficacy and Safety of DLBS3233 in Subjects With Polycystic Ovary Syndrome (PCOS)
|
Phase 3 | |
Completed |
NCT04264832 -
Body Fat Distribution and Its Associated Factors in Chinese Women With Polycystic Ovary Syndrome
|
||
Completed |
NCT03547453 -
Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome
|
||
Terminated |
NCT02865915 -
MLE4901 vs. Placebo for the Treatment of PCOS
|
Phase 2 | |
Completed |
NCT02429128 -
14 Weeks Exercise Training on Lean Women With and Without PCOS
|
N/A | |
Completed |
NCT01899001 -
Mood and Nutrition Interventions in Polycystic Ovary Syndrome
|
N/A | |
Completed |
NCT03151005 -
The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
|
Phase 4 | |
Completed |
NCT03792282 -
Time-Restricted Feeding(TRF) on Overweight/Obese Women With Polycystic Ovarian Syndrome (PCOS)
|
N/A | |
Completed |
NCT04852510 -
Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin
|
Phase 2/Phase 3 | |
Recruiting |
NCT05200793 -
Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome
|
Phase 4 | |
Not yet recruiting |
NCT01720459 -
Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients
|
N/A |